Merck advances cancer innovation by expanding role of Keytruda across new tumor
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with Spinal Muscular Atrophy (SMA)
Subscribe To Our Newsletter & Stay Updated